Skip to content

Study on the relationship between Lymphocyte subsets, tumor Necrosis Factor-a and TCM Syndromes of Depression

Study on the relationship between Lymphocyte subsets, tumor Necrosis Factor-a and TCM Syndromes of Depression

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200005617
Enrollment
Unknown
Registered
2022-02-07
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

1:None

Sponsors

Zhejiang Litongde Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) meet the diagnostic criteria of ICD-10 depressive episode; 2) 17 items of Hamilton Depression scale (Hamilton rating scale for depression, HAMD) score > 7; 3) 14-65 years old, regardless of sex, education, occupation, economic status, etc.; 4) No serious heart, liver and kidney diseases, no brain organic diseases, no tumors, blood history, rheumatism, malnutrition and nervous system degeneration. 5) did not take immunomodulator and hormone preparation for at least half a year, and did not take antipyretic and analgesic drugs within 2 weeks; 6) patients were unconscious and could understand the contents of the scale and cooperate with treatment. 7) obtain informed consent.

Exclusion criteria

Exclusion criteria: 1) there are other mental disorders such as bipolar disorder, schizophrenia, or depressive episodes secondary to other mental or somatic diseases; 2) there are serious diseases such as heart, liver, kidney, blood, rheumatism, tumor, malnutrition and nervous system degeneration, there are brain organic diseases; 3) there is a history of abuse of tobacco, alcohol and other psychoactive substances. 4) taking immunomodulator and hormone preparation within half a year, taking antipyretic and analgesic drugs within 2 weeks, 5) patients with disturbance of consciousness and 6) no informed consent.

Design outcomes

Primary

MeasureTime frame
TNF-a;Lymphocyte subsets;

Countries

China

Contacts

Public Contactliulanying
balindaliu@163.com13516816012

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026